Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April W Armstrong

Showing results (361-370 of 434) with videos related to

Pageof 44
Sort By:
The Journal of Rheumatology. Supplement|June 3, 2018
Proceedings of the 2017 GRAPPA Collaborative Research Network MeetingDeepak R Jadon, Vinod Chandran, Carmel Stober, et al.
Journal of the American Academy of Dermatology|June 9, 2015
Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burdenErika L Hagstrom, Shivani Patel, Chante Karimkhani, et al.
Dermatology and Therapy|May 30, 2025
Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal SymptomsJoseph F Merola, Philip J Mease, April W Armstrong, et al.
The Journal of Rheumatology|June 3, 2014
The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meetingAlice B Gottlieb, April W Armstrong, Robin Christensen, et al.
The Journal of Investigative Dermatology|June 26, 2026
Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled TrialApril W Armstrong, Alyssa M Roberts, Gina Kostandy, et al.
American Journal of Clinical Dermatology|September 8, 2023
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III TrialsEric L Simpson, Andrew E Pink, Andrew Blauvelt, et al.
American Journal of Clinical Dermatology|November 15, 2024
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III StudiesEric L Simpson, Matthias Augustin, Diamant Thaçi, et al.
JAMA Dermatology|June 24, 2026
Online vs In-Person Care for Atopic Dermatitis: A Randomized Clinical TrialApril W Armstrong, Alyssa M Roberts, Gina Kostandy, et al.
Journal of the American Academy of Dermatology|December 7, 2019
Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trialsKristian Reich, Christopher E M Griffiths, Kenneth B Gordon, et al.
Journal of the American Academy of Dermatology|January 16, 2018
Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis FoundationScott M Whitlock, Clinton W Enos, April W Armstrong, et al.
Pageof 44

Showing results (361-370 of 434) with videos related to

Sort By:
Pageof 44
The Journal of Rheumatology. Supplement|June 3, 2018
Proceedings of the 2017 GRAPPA Collaborative Research Network MeetingDeepak R Jadon, Vinod Chandran, Carmel Stober, et al.
Journal of the American Academy of Dermatology|June 9, 2015
Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burdenErika L Hagstrom, Shivani Patel, Chante Karimkhani, et al.
Dermatology and Therapy|May 30, 2025
Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal SymptomsJoseph F Merola, Philip J Mease, April W Armstrong, et al.
The Journal of Rheumatology|June 3, 2014
The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meetingAlice B Gottlieb, April W Armstrong, Robin Christensen, et al.
The Journal of Investigative Dermatology|June 26, 2026
Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled TrialApril W Armstrong, Alyssa M Roberts, Gina Kostandy, et al.
American Journal of Clinical Dermatology|September 8, 2023
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III TrialsEric L Simpson, Andrew E Pink, Andrew Blauvelt, et al.
American Journal of Clinical Dermatology|November 15, 2024
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III StudiesEric L Simpson, Matthias Augustin, Diamant Thaçi, et al.
JAMA Dermatology|June 24, 2026
Online vs In-Person Care for Atopic Dermatitis: A Randomized Clinical TrialApril W Armstrong, Alyssa M Roberts, Gina Kostandy, et al.
Journal of the American Academy of Dermatology|December 7, 2019
Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trialsKristian Reich, Christopher E M Griffiths, Kenneth B Gordon, et al.
Journal of the American Academy of Dermatology|January 16, 2018
Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis FoundationScott M Whitlock, Clinton W Enos, April W Armstrong, et al.
Pageof 44